New Delhi, Pharma major Lupine Ltd on Thursday announced the appointment of former Pfizer Chairman and CEO, Jeffrey Kindler and Alfonso 'Chito' Zulueta as independent directors to its board.
Lupine said in a regulatory filing that Kindler is currently the CEO of Centrexion Therapeutics, a privately held biotechnology company, senior advisor at Blackstone, operating partner at ARTI Ventures and global chair of the GLG Institute.
He has more than four decades of business experience, the company said, holding leadership positions at some of the world's most recognized companies, including Pfizer, where he served as chairman and chief executive officer, as well as McDonald's Corporation and General Electric. Have also worked in the company.
Prior to this, he was a partner at the law firm Williams & Connolly.
Zulueta currently serves as non-executive chairman of the board of directors of InterPharma Investments Ltd., the holding company of Zweilig Pharma, one of Asia's largest healthcare groups, Lupin said.
He is also the Chairman and CEO of CZ Ventures, a company focused on start-up investments, and a member of the board of directors of Gluco, CTS Corporation and Bridge Payday Solutions.
It says he spent more than three decades with Eli Lilly and Company in various roles of increasing responsibility.
Vineeta Gupta, CEO, Lupine, said, “His extensive experience in building healthcare institutions, strategic outlook of our industry and deep understanding of the emerging global pharmaceutical landscape will enable us to pursue our growth plans in the years to come.”
Lupine said in a regulatory filing that Kindler is currently the CEO of Centrexion Therapeutics, a privately held biotechnology company, senior advisor at Blackstone, operating partner at ARTI Ventures and global chair of the GLG Institute.
He has more than four decades of business experience, the company said, holding leadership positions at some of the world's most recognized companies, including Pfizer, where he served as chairman and chief executive officer, as well as McDonald's Corporation and General Electric. Have also worked in the company.
Prior to this, he was a partner at the law firm Williams & Connolly.
Zulueta currently serves as non-executive chairman of the board of directors of InterPharma Investments Ltd., the holding company of Zweilig Pharma, one of Asia's largest healthcare groups, Lupin said.
He is also the Chairman and CEO of CZ Ventures, a company focused on start-up investments, and a member of the board of directors of Gluco, CTS Corporation and Bridge Payday Solutions.
It says he spent more than three decades with Eli Lilly and Company in various roles of increasing responsibility.
Vineeta Gupta, CEO, Lupine, said, “His extensive experience in building healthcare institutions, strategic outlook of our industry and deep understanding of the emerging global pharmaceutical landscape will enable us to pursue our growth plans in the years to come.”
